Wesana Health Holdings Inc.
WSNAF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$209
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $209.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.05 |
| Beta | -0.7 |
| Outstanding Shares | 35,039,393 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
$-0.12
Consensus analyst estimateRevenue Estimate
$233,000
Consensus analyst estimateNext Earnings Call
Expected Date
November 30, 2026
EPS Estimate
$-0.12
Consensus analyst estimateRevenue Estimate
$233,000
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Wesana Health Holdings Inc.
7 employees
CEO: Daniel Carcillo
Wesana Health Holdings Inc. is a life sciences firm dedicated to advancing and providing psychedelic-based therapies, including psilocybin-enhanced psychotherapy, primarily targeting the treatment of traumatic brain injuries (TBI). The c...